#BreatheForPulmonaryFibrosis
Remember to always enjoy life and keep breathing. Read the most recent news on Pulmonary Fibrosis. Click here: http://bit.ly/1lfMsiZ…
Remember to always enjoy life and keep breathing. Read the most recent news on Pulmonary Fibrosis. Click here: http://bit.ly/1lfMsiZ…
Meet Dyane. She shares what she fears most about her pulmonary fibrosis diagnosis and explains how this diagnosis has impacted her life. The thing she hates the most is not being able to be an active grandmother, with her eight grandchildren. Watch the video to hear her story.
Watch the video to learn more about pulmonary diseases, lung functions, COPD, types of emphysema, and its symptoms and diagnosis. Learn more about Pulmonary Fibrosis and Emphysema: http://bit.ly/1ONmRdG…
A team of researchers from the Department of Clinical and Experimental Medicine at the University of Catania, Italy recently reviewed the co-occurrence of additional diseases in Idiopathic Pulmonary Fibrosis and their current therapeutic strategies. The study, entitled “IPF, comorbidities and management implications,“ was published in the Sarcoidosis Vasculitis…
Findings by a team of researchers suggest that levels of circulating endothelial cells and fibrocytes may be used as predictive biomarkers in idiopathic pulmonary fibrosis (IPF). The team’s study, “Levels of circulating endothelial cells are low in idiopathic pulmonary fibrosis and are further reduced by anti-fibrotic treatments,” was published in…
Asha is a young woman who has the daily challenge of living with Lupus and Pulmonary Fibrosis. Watch this video of her talking about her own story and how it is to live with these diseases. Learn more about Pulmonary Fibrosis: http://bit.ly/1lfMsiZ and Lupus: http://bit.ly/1TXhzeU…
https://www.youtube.com/watch?v=zKQg8dyKafM Learn about Pulmonary Fibrosis, its causes and clinical trials being planned. Learn more about Pulmonary Fibrosis: http://bit.ly/1lfMsiZ…
Afferent Pharmaceuticals, a biotechnology company dedicated to therapies for neurogenic disorders, recently announced the beginning of a Phase 2 clinical trial to assess its candidate product AF-219 for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF). Neurogenic disorders are conditions associated with the…
Read the articles: 1. Potential Therapy for Severe Lung Disease Advances at aTyr Pharma 2. IPF Experts Discuss Disease Diagnosis and Treatment at CHEST 2015 3. Potential IPF Disease Biomarkers Seen in Patients’ Blood …
Emphysema is a type of lung disease that causes shortness of breath. In a person with emphysema, the alveoli are damaged. The alveoli walls and the elastic fibers are damaged and lost. Learn more about Emphysema and Pulmonary Fibrosis: http://bit.ly/1ONmRdG…
Visit the Pulmonary Fibrosis News forums to connect with others in the PF community.
Get regular updates to your inbox.